Google Health will integrate Flo’s health insights as its premier women’s health feature, creating co-branded products that fuse Flo’s reproductive-health expertise with Google’s wearable hardware and sensors.

Beginning in early 2027, Flo users can opt to sync Fitbit data—sleep, heart rate, heart-rate variability, skin temperature, and respiratory rate—with Flo to improve cycle predictions and symptom insights.

Flo reports roughly 500 million downloads and over 80 million active monthly users, while Google has launched the $100 Fitbit Air with an AI health coach earlier in the year.

Investors should watch adoption rates, sustained engagement, and the practical impact of integrated lab tests on user behavior rather than focusing solely on how many tests are integrated.

Risks for investors include user data-sharing adoption, regulatory scrutiny, health-AI accuracy, and whether the collaboration translates into new subscriptions or hardware revenue, all while maintaining trust around sensitive data.

Privacy caveats center on concerns about sharing sensitive health data and the dependence on user adoption and perceived insight quality to drive ongoing engagement.

Medical Intelligence will translate lab results into understandable, actionable daily guidance.

The partnership aims to link daily habits—sleep, training, nutrition—with biological markers to reveal relationships over time.

Key health areas include cardiovascular and metabolic markers (ApoB, Lipoprotein(a), fasting insulin, hs-CRP) and hormone/nutrient health (thyroid, sex hormones, nutrients).

The integration will launch as an opt-in feature early next year, with explicit permission required for each data category and purpose, and the option to revoke access anytime.

The partnership will support research into underserved women’s health topics, including perimenopause, PMOS, pregnancy, and postpartum recovery.

Function emphasizes a mission of 100 healthy years for 8 billion people, promoting its MI Lab and affordable access to 160+ tests plus optional MRI/CT scans.